Does FLUCICLOVINE F-18 Cause Injection site extravasation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site extravasation have been filed in association with FLUCICLOVINE F-18 (Axumin). This represents 4.9% of all adverse event reports for FLUCICLOVINE F-18.
5
Reports of Injection site extravasation with FLUCICLOVINE F-18
4.9%
of all FLUCICLOVINE F-18 reports
0
Deaths
0
Hospitalizations
How Dangerous Is Injection site extravasation From FLUCICLOVINE F-18?
Of the 5 reports.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FLUCICLOVINE F-18. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does FLUCICLOVINE F-18 Cause?
Positron emission tomogram abnormal (22)
Therapeutic response unexpected (20)
No adverse event (18)
Scan abnormal (11)
False negative investigation result (8)
Drug ineffective (6)
Off label use (5)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which FLUCICLOVINE F-18 Alternatives Have Lower Injection site extravasation Risk?
FLUCICLOVINE F-18 vs FLUCLOXACILLIN
FLUCICLOVINE F-18 vs FLUCONAZOLE
FLUCICLOVINE F-18 vs FLUCYTOSINE
FLUCICLOVINE F-18 vs FLUDARABINE
FLUCICLOVINE F-18 vs FLUDEOXYGLUCOSE F-18